Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary histiocytosis X].

R Loddenkemper1

  • 1Inneren Abteilung, Lungenklinik Heckeshorn des Krankenhauses Zehlendorf, Berlin.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|October 1, 1990
PubMed
Summary

Pulmonary histiocytosis X, a rare lung disorder, primarily affects smokers aged 20-40. Early diagnosis via bronchoalveolar lavage and prompt corticosteroid treatment can prevent disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[125 Years German Central Committee for the Fight against Tuberculosis (DZK)].

Pneumologie (Stuttgart, Germany)·2020
Same author

Improving outcomes for lung disease in Africa.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

[Pulmonary Medicine and its Institutions During National Socialism].

Pneumologie (Stuttgart, Germany)·2018
Same author

Chemotherapy in bone and joint tuberculosis.

Der Orthopade·2017
Same author

[On the History and Future of Thoracoscopy].

Pneumologie (Stuttgart, Germany)·2016
Same author

Pneumologie (Stuttgart, Germany)·2016

Area of Science:

  • Pulmonary Medicine
  • Immunopathology
  • Radiology

Context:

  • Pulmonary histiocytosis X (PHX) is a rare histiocytic granulomatosis with unknown etiology.
  • It affects approximately 5% of patients compared to sarcoidosis.
  • The condition predominantly impacts smokers between 20 and 40 years old.

Purpose:

  • To outline the key clinical features, diagnostic methods, and therapeutic approaches for Pulmonary Histiocytosis X.
  • To highlight the diagnostic utility of bronchoalveolar lavage (BAL) in PHX.
  • To emphasize the role of early corticosteroid therapy in managing the disease.

Summary:

  • PHX presents with non-productive cough and dyspnea, often incidentally detected on chest X-rays showing nodular and reticular changes.
  • Tomography may reveal characteristic ring figures, aiding diagnosis.
  • While traditionally diagnosed via lung biopsy, bronchoalveolar lavage is now a viable diagnostic tool.

Impact:

  • Early diagnosis and intervention with corticosteroids can halt the progression of PHX to a fibrotic-bullous end-stage.
  • Improved diagnostic techniques like BAL enhance patient outcomes.
  • Understanding PHX contributes to the broader knowledge of interstitial lung diseases.

Related Experiment Videos